News coverage about Zeltiq Aesthetics (NASDAQ:ZLTQ) has been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Zeltiq Aesthetics earned a coverage optimism score of 0.15 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 45.2334131183427 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Here are some of the news headlines that may have impacted Accern Sentiment’s rankings:

ZLTQ has been the subject of several recent research reports. Aegis reissued a “hold” rating and issued a $56.00 price target on shares of Zeltiq Aesthetics in a research note on Monday, April 24th. Zacks Investment Research raised shares of Zeltiq Aesthetics from a “hold” rating to a “buy” rating and set a $63.00 price target for the company in a research note on Thursday, April 13th. Eight investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Zeltiq Aesthetics presently has a consensus rating of “Hold” and a consensus price target of $55.58.

Zeltiq Aesthetics (NASDAQ:ZLTQ) remained flat at $56.48 during mid-day trading on Thursday. The firm has a 50 day moving average price of $56.05 and a 200-day moving average price of $46.95. Zeltiq Aesthetics has a 12-month low of $23.58 and a 12-month high of $56.50.

COPYRIGHT VIOLATION WARNING: This piece was reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at

Zeltiq Aesthetics Company Profile

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians.

Insider Buying and Selling by Quarter for Zeltiq Aesthetics (NASDAQ:ZLTQ)

Receive News & Ratings for Zeltiq Aesthetics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.